NEW YORK, July 2 - A Harvard Bioscience subsidiary said yesterday it has acquired British spectrophotometer maker Walden Precision Apparatus for an undisclosed amount.
A spokesperson said that as Walden leaves its Linton, UK, base to join its new parent, Biochrom, in neighboring Cambridge at the end of September, "some employees" will not be asked to stay on. The spokesman, David Green, would not elaborate.
Walden Precision primary designs, manufactures and markets a line of inexpensive diode-array spectrophotometers. Biochrom hopes that acquiring the line will bolster its own range of mid- and high-end spectrophotometers.
Though Biochrom's own line of spectrophotometers is sold worldwide by Amersham Biosciences, the Harvard Bioscience unit said it may enlist the help of Walden's distributors to sell the recently released mid-range tools.
Harvard Bioscience said the acquisition, in the works for between three and six months, would contribute about $750,000 in revenues this year and as much as $2 million in 2003.